Additional file 1 of TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer

Authors :: Liu, Yixuan
Zhu, Keyu
Guan, Xiaolin
Xie, Suhong
Wang, Yanchun
Tong, Ying
Guo, Lin
Zheng, Hui
Lu, Renquan
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 1: Fig. S1. (A) Tissue chip of TTK expression in ovarian tumor tissues and normal controls. (B) Tissue chip of TTK protein in cisplatin-sensitive and cisplatin-resistant ovarian tumor tissues. (C) TTK expression was reduced after cisplatin treatment in A2780 cells.

Subjects :: endocrine system
endocrine system diseases
female genital diseases and pregnancy complications

Full Text Access

Tools